Technical Analysis for MYX - Mayne Pharma Group Ltd
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.28% | |
Bollinger Band Squeeze | Range Contraction | 0.28% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.28% | |
Above Upper BB | Strength | 0.28% | |
Upper Bollinger Band Touch | Strength | 0.28% |
Alert | Time |
---|---|
Down 1% | about 21 hours ago |
Fell Below Upper Bollinger Band | about 22 hours ago |
Rose Above Previous Day's High | about 23 hours ago |
Up 1% | about 23 hours ago |
Upper Bollinger Band Resistance | 1 day ago |
Get a Trading Assistant
Mayne Pharma Group Ltd Description
Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Manufacturing Pharmaceutical Pharmaceuticals Pharmaceutical Industry Pharmaceuticals Policy Pharmaceutical Products Pharmaceutical Industry In China Drug Delivery Science And Technology In The People's Republic Of China Contract Manufacturing Contract Manufacturing Services Contract Services Pharmaceutical Companies Generic Drug Generic Pharmaceutical Product Generic Pharmaceutical Products Manufacturing Services Pharmaceutical Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.35 |
52 Week Low | 2.75 |
Average Volume | 213,746 |
200-Day Moving Average | 4.855 |
50-Day Moving Average | 6.061 |
20-Day Moving Average | 6.965 |
10-Day Moving Average | 6.965 |
Average True Range | 0.258 |
RSI (14) | 69.04 |
ADX | 42.98 |
+DI | 33.701 |
-DI | 13.120 |
Chandelier Exit (Long, 3 ATRs) | 6.576 |
Chandelier Exit (Short, 3 ATRs) | 7.164 |
Upper Bollinger Bands | 7.246 |
Lower Bollinger Band | 6.684 |
Percent B (%b) | 0.99 |
BandWidth | 8.066 |
MACD Line | 0.271 |
MACD Signal Line | 0.297 |
MACD Histogram | -0.0268 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.570 | ||||
Resistance 3 (R3) | 7.560 | 7.440 | 7.515 | ||
Resistance 2 (R2) | 7.440 | 7.356 | 7.445 | 7.497 | |
Resistance 1 (R1) | 7.340 | 7.304 | 7.280 | 7.350 | 7.478 |
Pivot Point | 7.220 | 7.220 | 7.190 | 7.225 | 7.220 |
Support 1 (S1) | 7.120 | 7.136 | 7.060 | 7.130 | 7.002 |
Support 2 (S2) | 7.000 | 7.084 | 7.005 | 6.983 | |
Support 3 (S3) | 6.900 | 7.000 | 6.965 | ||
Support 4 (S4) | 6.910 |